Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 11:46 am Unchanged | 13G | Phathom Pharmaceuticals Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 0 (Unchanged) | View |
| 2024-11-04 11:20 am Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | JENNISON ASSOCIATES LLC | 6,993,422 10.400% | 6,993,422 (New Position) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | BlackRock Inc. BLK | 3,122,570 5.200% | 3,122,570 (New Position) | View |
| 2024-08-22 4:05 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 12,788,710 18.000% | 2,618,922 (+25.75%) | View |
| 2024-06-06 1:59 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 10,169,788 17.400% | 44,000 (+0.43%) | View |
| 2024-04-10 06:10 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 2,790,480 4.800% | -362,737 (-11.50%) | View |
| 2024-04-01 06:15 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,153,217 5.400% | -602,366 (-16.04%) | View |
| 2024-02-12 4:36 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | View |
| 2024-02-09 11:45 am Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Invesco Ltd. IVZ | 3,167,653 5.500% | 960,004 (+43.49%) | View |
| 2024-01-26 4:00 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Medicxi Growth I LP | 7,464,572 13.000% | 4,980,298 (+200.47%) | View |
| 2024-01-25 06:11 am Sale | 13D | Phathom Pharmaceuticals Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 3,755,583 6.600% | -3,703,721 (-49.65%) | View |
| 2023-05-26 5:29 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 10,125,788 18.500% | 1,697,683 (+20.14%) | View |
| 2023-05-05 4:13 pm Purchase | 13D | Phathom Pharmaceuticals Inc. PHAT | Frazier Life Sciences Public Fund L.P. | 8,428,105 19.300% | 8,428,105 (New Position) | View |
| 2023-03-09 4:17 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Carlyle Group Inc. CG | 2,935,106 6.700% | 2,935,106 (New Position) | View |
| 2023-02-14 1:58 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Avidity Partners Management LP | 1,900,000 4.600% | 4,000 (+0.21%) | View |
| 2023-02-10 3:59 pm Sale | 13G | Phathom Pharmaceuticals Inc. PHAT | Flynn James E | 0 0.000% | -2,414,897 (Position Closed) | View |
| 2023-02-09 11:30 am Sale | 13G | Phathom Pharmaceuticals Inc. PHAT | VANGUARD GROUP INC | 1,076,605 2.590% | -851,239 (-44.15%) | View |
| 2023-02-09 11:18 am Sale | 13G | Phathom Pharmaceuticals Inc. PHAT | JANUS HENDERSON GROUP PLC JHG | 2,952 0.000% | -1,838,405 (-99.84%) | View |
| 2023-02-02 3:08 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Invesco Ltd. IVZ | 2,207,649 5.300% | 140,293 (+6.79%) | View |
| 2023-01-31 4:00 pm Purchase | 13G | Phathom Pharmaceuticals Inc. PHAT | Medicxi Growth I LP | 2,484,274 6.000% | 416,413 (+20.14%) | View |